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Abstract
Six isolates of the Candida parapsilosis complex with different enzymatic profiles were
used to induce systemic infection in immunocompetent BALB/c mice. Fungal tissue bur-
den was determined on days 2, 5, 10, and 15 post challenge. The highest fungal load
irrespective of post-infection day was detected in the kidney, followed by the spleen,
lung, and liver, with a tendency for the fungal burden to decrease by day 15 in all groups.
Significant differences among the strains were not detected, suggesting that the three
species of the “psilosis” group possess a similar pathogenic potential in disseminated
candidiasis regardless of their enzymatic profiles.
Key words: murine model, disseminated candidiasis, Candida parapsilosis, Candida orthopsilosis, Candida metap-
silosis, fungal tissue burden.
Introduction
Candida parapsilosis, C. orthopsilosis, and C. metapsilosis,
which comprise the “psilosis” group, are a cryptic species
that frequently cause opportunistic infections. These infec-
tions are associated with high morbidity and mortality rates
in hospitalized immune-compromised patients [1], princi-
pally among the pediatric population [2]. These yeasts have
been the subject of an increasing number of epidemiologi-
cal surveys [3,4], as well as in vitro studies of extracellular
hydrolytic enzymes [5,6] and biofilm production capability
[7,8].
To date there are limited reports that focus on the
pathogenic potential of psilosis group members. Ga´cser
et al. studied the in vitro behavior of the three species in oral
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epithelium and epidermis and reported similar histopatho-
logical alterations due to C. parapsilosis and C. orthopsilo-
sis in both tissues. However, C. metapsilosis induced min-
imal damage when compared with uninfected controls [9].
In a different context, Orsi et al. established that C. metap-
silosis was more susceptible to microglia-mediated antifun-
gal activity when compared with C. parapsilosis and C. or-
thopsilosis [10]. Overall, these findings led to C. metap-
silosis being considered the least virulent member of the
C. parapsilosis complex, as recently confirmed by Bertini
et al. [11].
Our aim in this study was to evaluate the in vivo
pathogenicity of C. parapsilosis, C. orthopsilosis, and
C. metapsilosis in a murine model of disseminated can-
didiasis. Furthermore, we investigated possible correlations
of the in vivo pathogenicity of the tested strains with their
in vitro aspartyl proteinase, phospholipase, esterase, and
hemolysin activities.
Materials and methods
Strains
Two strains of each of the following species were included in
this study:C. parapsilosis sensu stricto (c/c 105 andH-124),
C. orthopsilosis (HP-179 and H-152), and C. metapsilosis
(MEX-18 and ATCC (American Type Culture Collection)-
96144). Species identification of the strains was initially per-
formed using restriction fragment length polymorphism–
BanI digestion assays [12] and confirmed by sequencing the
noncoding rRNA internal transcribed spacer region using
the universal primers reported by White et al. [13]. The
obtained sequences were submitted to GenBank with the
accession numbers cited in Table 1. The strains were stored
as suspensions in sterile distilled water at room temperature
and cultured for 48 h on Sabouraud glucose agar (SGA)
slants (Difco, Detroit, MI, USA) at 37◦C before use in the
investigations.
Enzymatic determinations
The in vitro evaluation of extracellular hydrolytic enzymes
of the strains was determined using plate assays as described
in our previous work [5]. Briefly, aspartyl proteinase activ-
ity was assayed using yeast carbon base–bovine serum albu-
min test medium reported by Chakrabarti et al. [14]; phos-
pholipase activity was evaluated according to the method-
ology proposed by Price et al. [15]; Tween 80 opacity test
medium was used to determine esterase activity [16]; and
hemolysin activity was examined using the experimental
strategy established by Luo et al. [17]. The activity was
expressed according to the Pz index, that is, colony diam-
eter/total diameter of the colony plus the precipitation or
halo zone [18]. The type strain C. albicans ATCC 90028
was used as the quality control for all enzymatic activity
determinations. The assays were conducted twice.
Inocula preparation
The strains were passed at least twice on SGA plates to
check the cultures’ purity and viability. After 48 h of incu-
bation at 37◦C, yeast cells were harvested, washed twice in
sterile saline, their concentration quantified with a hemo-
cytometer, and adjusted to the desired concentration. To
corroborate the yeast cell counts, serial dilutions were cul-
tured on SGA plates at 37◦C for 48 h.
Animals
Male BALB/c mice aged 5 weeks (weighing 22–24 g; pur-
chased fromHarlanMexico) were used for the in vivo stud-
ies. A total of 132 animals were used; the animals were
Table 1. Enzymatic profiles of strains used in vivo studies.
Pz indexa
Strain GenBank Clinical origin Aspartyl Phospholipase Esterase Hemolysin
accession number proteinase
Candida parapsilosis
c/c 105 KC777378 Peritoneal fluid 1 0.77 0.53 0.73
H-124 KC777379 Blood 1 1 1 1
C. orthopsilosis
HP-179 KC777377 Blood 1 0.68 0.56 0.75
H-152 KC777376 Blood 0.70 1 1 1
C. metapsilosis
M-18 KC777375 Skin 0.44 0.79 1 0.77
ATCC 96144 KC777380 Skin 1 0.80 1 1
aPz index: very strong, Pz < 0.69; strong, Pz = 0.70–0.79; mild, Pz = 0.80–0.89; weak, Pz = 0.90–0.99; negative, Pz = 1.
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housed in cages of five mice each. All mice were given food
and water ad libitum and were monitored daily for 15 days.
Care, maintenance, and handling of the animals were in ac-
cordance with theMexican government’s license conditions
for animal experimentation and the Guidelines for the Care
and Use of Laboratory Animals. Experiments were con-
ducted with the approval of the Ethics and Research Com-
mittee, Facultad de Medicina, UANL in Monterrey, Nuevo
Leo´n, Mexico (registration code MB12-002).
Experimental disseminated candidiasis
Twenty animals were infected intravenously through the
lateral tail vein with 1.5 × 107 CFU/mouse of each strain
in 200 µl of a yeast suspension. Three uninfected mice were
used as controls per experimental day. No immunosuppres-
sive scheme was used.
Fungal tissue burden assays
Five mice per strain were sacrificed by cervical disloca-
tion on experimental days 2, 5, 10, and 15 post infection.
After sacrifice, spleen, kidneys, liver, and lungs of each
mouse were immediately aseptically removed, weighed,
and placed in sterile phosphate-buffered saline solution
(138 mM NaCl, 3 mM KCl, 8.1 mM Na2HPO4, and
1.5 mM KH2PO4). The organs were mechanically homoge-
nized (Polytron-Aggregate, Kinematica) and serially diluted
1:10 in sterile saline. Aliquots of 0.1 ml of the undiluted and
diluted homogenates were then plated twice onto SGA
plates, and colony counts were performed after 48 h of
incubation at 37◦C. The entire in vivo experiment was per-
formed twice at different times.
Histopathology
After mice sacrifice, tissues were immediately removed and
fixed with 10% buffered formalin. Samples were dehy-
drated, paraffin embedded, and sliced into 5-µm sections.
The sections were stained with Grocott methenamine silver
and examined by light microscopy in a blinded fashion.
Statistics
The fungal tissue burdens of the tested organs in the differ-
ent experimental groups were analyzed using the Kruskal-
Wallis test in SPSS (SPSS version 17.0 for Windows; SPSS
Inc., Chicago, IL, USA). P≤0.05was considered significant.
Results
The strains used in this study were chosen on the basis
of their aspartyl proteinase, phospholipase, esterase, and
hemolysin in vitro activities (Table 1). One isolate of each
species was found to have phospholipase and hemolysin
activities, whereas activity for just one enzyme was noted
in their counterparts. However, strain H-124’s enzymatic
profile was negative for the four extracellular hydrolytic
enzymes included in the investigation. The fungal tissue
burden results are summarized in Table 2. Throughout the
course of infection, mice did not lose weight or have oc-
ular disorders and did not have motor impairment. How-
ever, slight pilo-erection episodes were sporadically noted
in mice, principally during the first 5 days post challenge.
In general, the highest fungal load of all six strains was de-
tected in kidney, followed by spleen, lung, and liver tested
on the 4 experimental days. The fungal burden tended to
decrease by day 15 post infection in all groups, as depicted
in Fig. 1. On day 2, the fungal load of the kidneys was statis-
tically significant in comparison with liver and lung, except
for strain H-152. Moreover, the fungal burden of the kid-
neys was significant compared with spleen, liver, and lung
by day 5, except in strains H-152 and ATCC 96144.
Since their reclassification as three phylogenetically in-
dependent species, C. parapsilosis sensu stricto, C. orthop-
silosis, and C. metapsilosis have been increasingly investi-
gated due to their possible clinical importance. Experimen-
tal models of disseminated candidiasis have been developed
principally in mice, and many of them focused on the thera-
peutic efficacy of antifungal treatment schemes [19,20] and
host immune responses against fungal infections [21,22].
However, one study of Candida spp. pathogenicity in a
murine model of systemic infection was previously pub-
lished by Arendrup et al. [23]. They reported that mice
infected with 107 CFU of C. parapsilosis did not die and
that yeasts were not detected in kidneys on day 7 post chal-
lenge [23]. Despite the fact that this report was our di-
rect antecedent, the results were different from ours, likely
because they used female CF1 mice and C. parapsilosis
strains that were not confirmed by molecular approaches
and because the experimental design of the their study
was somewhat dissimilar from ours. Later, Ga´cser et al.
demonstrated the important role of lipase in C. parapsilosis
virulence using an efficient gene deletion system based on
the nourseothricin resistance marker (caSAT1) and its sub-
sequent deletion by FLP-mediated [24]. They found that
the homozygous lipase-negative C. parapsilosis mutants
were significantly less virulent compared with the wild-type
strain when intraperitoneally inoculated in female BALB/c
mice. However, they reported no differences in fungal bur-
den or survival in the murine intravenous infection model
using inocula of 107 fungal cells [24]. Recently, Bertini et al.
tested the pathogenic potential of the C. parapsilosis com-
plex in estrogen-treated BALB/c mice during a vaginal infec-
tion with 106 yeasts and reported significant differences in
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Table 2. Fungal tissue burden results in mice intravenously infected with inocula of 1.5 × 107 CFU/mouse.
Log CFU/g tissue (median [range])
Strain Organ Days post- infection
(GenBank accession number) 2 5 10 15
Candida parapsilosis
c/c 105 Spleen 5.45 (5.28–5.57) 3.54 (3.45–3.91) 2.89 (0–3.08) 2.51 (0–2.83)
(KC777378) Kidney 5.30 (5.23–5.54) 4.15 (3.89–4.28) 2.46 (0–5.04) 2.32 (2.18–3.20)
Liver 4.72 (4.53–4.86) 2.43 (2.06–2.68) 1.40 (0–1.63) 1.67 (0–1.90)
Lung 4.23 (4.08–4.34) 3.11 (2.65–3.20) 2.15 (0–2.30) 2.20 (0–2.53)
H-124 Spleen 5.23 (5.11–5.38) 3.93 (3.71–4.26) 3.08 (2.43–3.59) 3.04 (2.43–3.28)
(KC777379) Kidney 5.20 (5.11–5.49) 4.28 (4.23–4.56) 4.63 (3.52–5.23) 4.83 (4.11–5.36)
Liver 3.97 (3.86–4.26) 2.79 (2.75–3.15) 1.77 (1.34–2.00) 1.93 (1.72–2.52)
Lung 4.36 (4.11–4.40) 3.46 (3.28–3.66) 2.72 (2.32–3.53) 3.23 (2.53–3.91)
C. orthopsilosis
HP-179 Spleen 5.40 (5.30–5.54) 3.56 (3.18–3.72) 2.83 (2.72–3.28) 0 (0–2.36)
(KC777377) Kidney 5.46 (5.40–5.54) 3.99 (3.72–4.08) 3.64 (3.08–4.08) 3.82 (2.67–4.54)
Liver 4.67 (4.40–4.78) 2.53 (2.52–2.78) 1.41 (0–1.89) 0 (0–1.78)
Lung 4.73 (4.41–4.94) 3.26 (3.11–3.38) 2.53 (2.36–2.68) 2.15 (0–2.89)
H-152 Spleen 5.43 (5.08–5.45) 3.81 (3.62–4.00) 2.57 (2.34–2.75) 2.57 (0–2.90)
(KC777376) Kidney 5.15 (5.04–5.20) 4.52 (4.26–5.15) 4.48 (4.28–5.23) 4.38 (3.91–4.86)
Liver 5.15 (5.04–5.20) 3.34 (3.23–3.52) 1.89 (1.32–3.04) 1.41 (0–1.51)
Lung 4.97 (4.80–5.23) 3.76 (3.51–4.04) 2.28 (0–2.81) 2.49 (0–3.11)
C. metapsilosis
M-18 Spleen 5.00 (4.83–5.15) 3.63 (3.34–3.72) 2.76 (2.66–3.08) 2.18 (0–2.26)
(KC777375) Kidney 5.11 (5.04–5.18) 4.40 (4.26–4.56) 4.48 (4.34–5.11) 3.34 (0–4.71)
Liver 4.04 (3.79–4.11) 2.62 (2.48–3.04) 2.11 (1.86–2.81) 1.30 (0–1.61)
Lung 4.58 (4.45–5.15) 3.28 (3.23–3.59) 3.00 (2.38–3.20) 2.26 (0–2.91)
ATCC 96144 Spleen 5.11 (4.85–5.32) 3.68 (2.87–3.98) 2.58 (2.45–3.15) 2.65 (0–3.38)
(KC777380) Kidney 5.00 (4.26–5.11) 4.11 (3.46–4.43) 4.11 (3.30–5.11) 4.36 (3.69–5.38)
Liver 4.41 (4.11–4.46) 2.81 (2.18–3.08) 1.88 (1.83–3.23) 2.11 (1.38–3.77)
Lung 4.34 (3.46–4.40) 3.54 (2.86–3.79) 2.68 (2.40–2.73) 2.58 (2.18–2.85)
infection kinetics among the psilosis group species [11].
Mice infectedwithC.metapsilosis displayed a reduced vagi-
nal fungal burden, as well as spontaneous infection clear-
ance at day 28 post challenge for all strains tested. However,
given that the physiopathological basis of the local vaginal
candidiasis is quite different from the disseminated disease,
coupled with the fact that the strains used by Bertini et al.
were not characterized according to enzymatic profiles, we
cannot contrast our results with those previously reported.
Although the in vitro enzymatic profile of the strains
showed important differences regarding their aspartyl pro-
teinase, phospholipase, esterase, and hemolysin activities,
significant differences among the psilosis group (in terms
of tissue fungal burden) were not detected when assayed in
vivo, indicating that possibly the three species of the com-
plex have a similar pathogenic potential in disseminated in-
fection in immunocompetent hosts, at least with the strains
tested in this study and under the experimental design of
our model. Further studies with more wholly characterized
strains are needed in order to prove this hypothesis. To our
knowledge, this is the first report looking for a correlation
between the in vivo pathogenicity of the C. parapsilosis
complex species with different in vitro enzymatic profiles.
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